FOXC1 | Citedby Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

FOXC1: A Specific Biomarker for Triple-Negative Breast Cancer Diagnosis and Classification

Arch Pathol Lab Med (2022) 146 (8): 994–1003.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Application of Gene Editing in Triple‐Negative Breast Cancer Research

Shuying Feng
Jixia Li
Aifen Yan
Xiangxing Zhu
Ligang Zhang
Dongsheng Tang
Lian Liu

Cell Biochemistry and Function (2025) 43 (1)

FOXC1 and SOX10 in Estrogen Receptor–Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction

Ming Li
Shuling Zhou
Hong Lv
Mengyuan Cai
Xiaochun Wan
Hongfen Lu
Ruohong Shui
Wentao Yang

Archives of Pathology & Laboratory Medicine (2024) 148 (4): 461.

TRPS1, a sensitive marker for different histological and molecular types of breast cancer

Change Kong
Baohua Yu
Rui Bi
Xiaoli Xu
Yufan Cheng
Wentao Yang
Ruohong Shui

Diagnostic Pathology (2024) 19 (1)

The Influence of FOXC1 Gene on Development, Organogenesis, and Functions

Shruti Biyani
Amol Somaji Patil
Vinit Swami

Clinical & Translational Metabolism (2024) 22 (1)

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

Filomena Marino Carvalho

Frontiers in Oncology (2023) 13

Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1

Yufei Wang
Gang Wang
Yingping Liu
Fangyu Yang
Hongshuo Zhang
Ying Kong

Phytomedicine (2023) 120: 155062.